ロード中...
Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges
Approximately 75% of patients with pancreatic ductal adenocarcinoma are diagnosed with advanced cancer, which cannot be safely resected. The most commonly used biomarker CA19-9 has inadequate sensitivity and specificity for early detection, which we define as Stage I/II cancers. Therefore, progress...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876642/ https://ncbi.nlm.nih.gov/pubmed/29518918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10030067 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|